Pomelo Care has secured $92 million in Series C funding, taking the company’s valuation to $1.7 billion, as it looks to extend its virtual care model beyond maternity and into broader women’s and children’s healthcare.
The funding round was led by Stripes, with participation from Andreessen Horowitz, PLUS Capital, Atomico, BoxGroup and SV Angel. The announcement was made on January 8, 2026. Pomelo said the investment follows strong clinical and financial results from its maternity care programme, which now supports nearly 7% of all births in the United States.
Pomelo Care said its model has been shown to reduce preterm births, neonatal intensive care unit (NICU) admissions and overall medical costs. The company currently partners with major health plans and employers and covers more than 25 million lives nationwide.
“Pomelo Care was founded to measurably improve maternal health in the United States,” said Marta Bralic Kerns, founder & CEO of Pomelo Care. “We’ve demonstrated that when care is proactive, evidence-based, and accountable, we improve outcomes and costs come down. Now, with this funding, we’re taking that proven model beyond maternity to build a system of care that supports women and children throughout their lives, delivering better results across the entire healthcare ecosystem—for patients, payers, providers, and employers alike.”
Founded in 2021, Pomelo delivers 24/7 virtual care through a multispecialty clinical team supported by data science. The company said its approach allows risks to be identified early and monitored continuously, while working alongside in-person providers to deliver coordinated care, particularly in areas facing workforce shortages and limited access to services.
Pomelo publishes and presents peer-reviewed, claims-based outcomes at national medical and scientific conferences. Reported results include a 37% reduction in preterm births, a 46% reduction in emergency room utilisation, a 6.8-day reduction in NICU length of stay, and prenatal depression screening and follow-up rates that are 718% higher than benchmarks.
The company said engagement with its services delivers a 3-5x return on investment for customers, driven by reductions in high-cost events such as preterm births, emergency visits and NICU stays.
Pomelo’s technology platform integrates evidence-based care pathways and predictive analytics into clinician workflows, enabling faster clinical decision-making. Patients can access care through phone, text, video and app-based services, supported by nurses, dietitians, therapists, doulas and licensed providers.
The company has also launched a midlife care programme focused on perimenopause and menopause. Pomelo reported an 88% reduction in symptoms within 60 days, measured by the Menopause Rating Scale, and said 73% of participants reported increased productivity.
“We are thrilled to double down on our partnership with Pomelo and are proud to support Marta and the entire Pomelo team on their mission to build a category-leading business in women’s and children’s healthcare,” said Ron Shah, Partner at Stripes. “Pomelo has reached national scale at an unprecedented rate — now serving 25 million covered lives through Commercial and Medicaid health plan partnerships across the United States. The power of Pomelo’s amazing product is clear: exceptional patient satisfaction and strong clinical results showing meaningful reductions in pregnancy-related complications. We believe Pomelo’s intelligent care platform will power continued rapid growth and product expansion, meeting rising demand from patients and payers with a modern clinical experience and best-in-class operating metrics.”
About Pomelo Care
Pomelo Care is the national leader in evidence-based healthcare for women and children. We deliver personalized, high-quality clinical interventions from reproductive care and pregnancy, infant care and pediatrics, to hormonal health through perimenopause and menopause, with long-term preventive care and condition management. Our model delivers 24/7 multispecialty care to address the medical, behavioral, and social factors that most significantly impact outcomes for women and children. We partner with payers, employers, and providers to expand access to quality healthcare across the system. Learn more at pomelocare.com.
